Exploring the anti-gastric cancer mechanisms of Diosgenin through integrated network analysis, bioinformatics, single-cell sequencing, and cell experiments
These findings highlight Diosgenin's potential as a promising therapeutic agent for GC, offering a foundation for future research and clinical applications.
Authors
- Sui-Cai Mi (ORCID: https://orcid.org/0000-0002-1378-9915)
- Zhangjun Yun (ORCID: https://orcid.org/0000-0002-3422-9140)
- Li Hou (ORCID: https://orcid.org/0000-0003-2921-0821)
- Yang Shen (ORCID: https://orcid.org/0000-0002-1077-7273)
- Liyuan Lv (ORCID: https://orcid.org/0000-0002-6693-8187)
- Qiwen Yang (ORCID: https://orcid.org/0009-0006-0195-4342)
- Chengyuan Xue
Institutions
- Beijing University of Chinese Medicine (CN)
- Xiamen University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fphar.2025.1600960
- Citations
- 1
- Primary Topic
- Phytochemical Studies and Bioactivities
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Fundamental Research Funds for the Central Universities